Clearmind Medicine, Inc. (CMND)

6.54 -0.04 (-0.61%) USD  |  NASDAQ  |  Oct 12, 16:00
6.45 -0.09 (-1.38%) After-Hours: 05:03
More

Clearmind Medicine Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for CMND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. Upgrade
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) --